losartan has been researched along with mannitol in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Blair-West, JR; Denton, DA; Tarjan, E; Weisinger, RS | 1 |
| Blair-West, JR; Burns, P; Denton, DA; Purcell, B; Weisinger, RS | 1 |
| Matsumura, M | 1 |
| Chen, QH; Toney, GM | 1 |
| Lin, XH; Lindholm, B; Qian, JQ; Yao, Q | 1 |
| Bayard, F; Eriksson, S; Frithiof, R; Rundgren, M; Svensson, T | 1 |
| Dhein, S; Hoyer, A; Kempfert, J; Mohr, FW; Pritzwald-Stegmann, P | 1 |
| Balogh, DB; Fekete, A; Genovese, F; Hodrea, J; Hosszu, A; Koszegi, S; Lakat, T; Lenart, L; Molnar, A; Sparding, N; Szabo, AJ; Szkibinszkij, E; Vannay, A; Wagner, L | 1 |
1 review(s) available for losartan and mannitol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
9 other study(ies) available for losartan and mannitol
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Role of brain angiotensin II in thirst and sodium appetite of sheep.
Topics: Analysis of Variance; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Appetite; Biphenyl Compounds; Brain; Cerebral Ventricles; Dehydration; Diet, Sodium-Restricted; Diuresis; Female; Imidazoles; Infusions, Parenteral; Losartan; Mannitol; Naphthyridines; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Saline Solution, Hypertonic; Saliva; Sheep; Sodium, Dietary; Tetrazoles; Thirst | 1997 |
Cerebral Na concentration, Na appetite and thirst of sheep: influence of somatostatin and losartan.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Appetite; Brain; Drinking; Female; Hypertonic Solutions; Losartan; Mannitol; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Saline Solution, Hypertonic; Sheep; Sodium; Sodium, Dietary; Somatostatin; Thirst | 2001 |
Mannitol-induced toxicity in a diabetic patient receiving losartan.
Topics: Acute Kidney Injury; Antihypertensive Agents; Diabetes Mellitus, Type 1; Diuretics, Osmotic; Drug Hypersensitivity; Drug Interactions; Humans; Hypertension; Losartan; Male; Mannitol; Middle Aged | 2001 |
AT(1)-receptor blockade in the hypothalamic PVN reduces central hyperosmolality-induced renal sympathoexcitation.
Topics: Angiotensin Receptor Antagonists; Animals; Blood Pressure; Glucose; Heart Rate; Homeostasis; Hypertonic Solutions; Kidney; Losartan; Male; Mannitol; Osmolar Concentration; Paraventricular Hypothalamic Nucleus; Pressoreceptors; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Saline Solution, Hypertonic; Sodium Chloride; Sympathetic Nervous System | 2001 |
Inhibition of the effect of high glucose on the expression of Smad in human peritoneal mesothelial cells.
Topics: Angiotensin II Type 1 Receptor Blockers; Blotting, Western; Cells, Cultured; Dialysis Solutions; DNA-Binding Proteins; Enzyme-Linked Immunosorbent Assay; Epithelial Cells; Genes, Tumor Suppressor; Glucose; Humans; Losartan; Mannitol; Peritoneal Cavity; Peritoneal Dialysis; RNA, Messenger; Signal Transduction; Smad2 Protein; Trans-Activators; Transforming Growth Factor beta; Up-Regulation | 2004 |
Intravenous hypertonic NaCl acts via cerebral sodium-sensitive and angiotensinergic mechanisms to improve cardiac function in haemorrhaged conscious sheep.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Cardiovascular System; Consciousness; Diuretics, Osmotic; Female; Hemorrhage; Hypovolemia; Infusions, Intravenous; Injections, Intraventricular; Losartan; Mannitol; Osmolar Concentration; Receptor, Angiotensin, Type 1; Resuscitation; Saline Solution, Hypertonic; Sheep; Sodium; Vascular Resistance; Vasopressins | 2007 |
Acute hemodynamic effects of angiotensin- converting enzyme inhibition after prolonged cardiac arrest with Bretschneider's solution.
Topics: Adenosine Triphosphate; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Endothelin Receptor Antagonists; Glucose; Heart Arrest; Hemodynamics; Losartan; Male; Malondialdehyde; Mannitol; Myocardial Reperfusion Injury; Oxygen Consumption; Peptides, Cyclic; Potassium Chloride; Procaine; Rabbits | 2014 |
RAAS inhibitors directly reduce diabetes-induced renal fibrosis via growth factor inhibition.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Cell Line; Connective Tissue Growth Factor; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Epithelial Cells; Eplerenone; Fibroblasts; Fibrosis; Humans; Kidney; Losartan; Male; Mannitol; Mineralocorticoid Receptor Antagonists; Proto-Oncogene Proteins c-sis; Ramipril; Rats, Wistar; Renin-Angiotensin System; Spironolactone | 2019 |